Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Novartis
Novartis
Pfizer
Novartis
Celgene
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Novartis